IDXX
IDEXX Laboratories, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-20
Figures on this page computed 2026-11-08 12:33 UTC
Last close
698.55USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-20
51.3xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-20
54.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
24.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
24.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
0.36Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.
- Growth9.7%59 of 100, above its sector
- Returns on capital54.3%98 of 100, above its sector
- Margins61.8%88 of 100, above its sector
- Price51.3x9 of 100, below its sector
- Safety0.3669 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9What it sells
3Where it sells it
6Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.
3 segments, 6 places and 0 named customers, each as the filer published it.
3 segments, 6 places and 0 named customers, each as the filer published it.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-20
Companion Animal Group Segment3,953,285,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Water Segment201,149,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Livestock And Poultry Diagnostics Segment131,787,000
- Source
- filed
- Statement
- segments
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
UNITED STATES2,752,785,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
EMEA937,252,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Asia Pacific355,929,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Europe, the Middle East, and Africa, Other230,031,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
CANADA167,325,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD
Latin America90,411,000
- Source
- filed
- Statement
- revenue_mix
- Fiscal year
- 2025
- Accession
- 0000874716-26-000038
- Reported in
- USD